vs
CAPRICOR THERAPEUTICS, INC.（CAPR）与SWK Holdings Corp（SWKH）财务数据对比。点击上方公司名可切换其他公司
CAPRICOR THERAPEUTICS, INC.的季度营收约是SWK Holdings Corp的1.3倍（$11.1M vs $8.7M），CAPRICOR THERAPEUTICS, INC.同比增速更快（-7.9% vs -29.7%），SWK Holdings Corp自由现金流更多（$26.8M vs $-15.3M），过去两年CAPRICOR THERAPEUTICS, INC.的营收复合增速更高（93.0% vs -12.5%）
Capricor Therapeutics是一家处于临床阶段的生物技术企业，专注于研发及商业化细胞疗法、基因疗法等创新生物制剂，覆盖罕见病、心血管疾病、肌肉疾病等领域，主要面向美国市场，致力为治疗选择有限的患者填补未被满足的医疗需求。
SWK Holdings Corp是一家专注于医疗健康与生命科学领域的专业金融企业，为生物技术、制药、医疗器械及诊断类企业提供特许权使用费货币化、结构性债务、资产支持贷款等定制化融资服务，核心市场以北美地区为主。
CAPR vs SWKH — 直观对比
营收规模更大
CAPR
是对方的1.3倍
$8.7M
营收增速更快
CAPR
高出21.8%
-29.7%
自由现金流更多
SWKH
多$42.1M
$-15.3M
两年增速更快
CAPR
近两年复合增速
-12.5%
损益表 — Q4 FY2024 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $11.1M | $8.7M |
| 净利润 | $-7.1M | $-19.4M |
| 毛利率 | — | — |
| 营业利润率 | -69.1% | 9.9% |
| 净利率 | -63.9% | — |
| 营收同比 | -7.9% | -29.7% |
| 净利润同比 | -833.8% | -430.2% |
| 每股收益（稀释后） | $-0.11 | $-1.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CAPRSWKH
| Q4 25 | — | $8.7M | ||
| Q3 25 | — | $10.9M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $11.8M | ||
| Q4 24 | $11.1M | $12.4M | ||
| Q3 24 | $2.3M | $10.4M | ||
| Q2 24 | $4.0M | $10.8M | ||
| Q1 24 | $4.9M | $11.4M |
净利润CAPRSWKH
| Q4 25 | — | $-19.4M | ||
| Q3 25 | — | $8.8M | ||
| Q2 25 | — | $3.5M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | $-7.1M | $5.9M | ||
| Q3 24 | $-12.6M | $3.5M | ||
| Q2 24 | $-11.0M | $3.7M | ||
| Q1 24 | $-9.8M | $468.0K |
营业利润率CAPRSWKH
| Q4 25 | — | 9.9% | ||
| Q3 25 | — | 61.3% | ||
| Q2 25 | — | 46.1% | ||
| Q1 25 | — | 68.6% | ||
| Q4 24 | -69.1% | 44.7% | ||
| Q3 24 | -575.2% | 39.2% | ||
| Q2 24 | -291.9% | 8.3% | ||
| Q1 24 | -209.2% | 9.5% |
净利率CAPRSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 80.7% | ||
| Q2 25 | — | 35.2% | ||
| Q1 25 | — | 38.4% | ||
| Q4 24 | -63.9% | 47.5% | ||
| Q3 24 | -555.2% | 33.3% | ||
| Q2 24 | -277.0% | 33.9% | ||
| Q1 24 | -199.6% | 4.1% |
每股收益（稀释后）CAPRSWKH
| Q4 25 | — | $-1.59 | ||
| Q3 25 | — | $0.72 | ||
| Q2 25 | — | $0.29 | ||
| Q1 25 | — | $0.37 | ||
| Q4 24 | $-0.11 | $0.47 | ||
| Q3 24 | $-0.38 | $0.28 | ||
| Q2 24 | $-0.35 | $0.30 | ||
| Q1 24 | $-0.31 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $151.5M | $42.8M |
| 总债务越低越好 | — | $33.0M |
| 股东权益账面价值 | $145.5M | $235.1M |
| 总资产 | $170.5M | $272.4M |
| 负债/权益比越低杠杆越低 | — | 0.14× |
8季度趋势，按日历期对齐
现金及短期投资CAPRSWKH
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $29.8M | ||
| Q4 24 | $151.5M | $5.9M | ||
| Q3 24 | $85.0M | $17.2M | ||
| Q2 24 | $29.5M | $5.5M | ||
| Q1 24 | $39.9M | $5.5M |
总债务CAPRSWKH
| Q4 25 | — | $33.0M | ||
| Q3 25 | — | $33.0M | ||
| Q2 25 | — | $33.0M | ||
| Q1 25 | — | $33.0M | ||
| Q4 24 | — | $33.0M | ||
| Q3 24 | — | $33.0M | ||
| Q2 24 | — | $33.0M | ||
| Q1 24 | — | $33.0M |
股东权益CAPRSWKH
| Q4 25 | — | $235.1M | ||
| Q3 25 | — | $254.2M | ||
| Q2 25 | — | $246.5M | ||
| Q1 25 | — | $292.7M | ||
| Q4 24 | $145.5M | $288.7M | ||
| Q3 24 | $68.3M | $283.4M | ||
| Q2 24 | $11.5M | $282.8M | ||
| Q1 24 | $18.4M | $279.9M |
总资产CAPRSWKH
| Q4 25 | — | $272.4M | ||
| Q3 25 | — | $289.4M | ||
| Q2 25 | — | $285.7M | ||
| Q1 25 | — | $331.3M | ||
| Q4 24 | $170.5M | $332.2M | ||
| Q3 24 | $93.0M | $321.3M | ||
| Q2 24 | $38.3M | $321.0M | ||
| Q1 24 | $49.4M | $322.0M |
负债/权益比CAPRSWKH
| Q4 25 | — | 0.14× | ||
| Q3 25 | — | 0.13× | ||
| Q2 25 | — | 0.13× | ||
| Q1 25 | — | 0.11× | ||
| Q4 24 | — | 0.11× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-14.8M | $27.3M |
| 自由现金流经营现金流 - 资本支出 | $-15.3M | $26.8M |
| 自由现金流率自由现金流/营收 | -137.3% | 308.1% |
| 资本支出强度资本支出/营收 | 4.4% | 5.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-41.2M | $43.2M |
8季度趋势，按日历期对齐
经营现金流CAPRSWKH
| Q4 25 | — | $27.3M | ||
| Q3 25 | — | $906.0K | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | $-14.8M | $23.0M | ||
| Q3 24 | $-11.6M | $6.3M | ||
| Q2 24 | $-12.3M | $5.4M | ||
| Q1 24 | $-1.3M | $4.4M |
自由现金流CAPRSWKH
| Q4 25 | — | $26.8M | ||
| Q3 25 | — | $557.0K | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | — | $8.2M | ||
| Q4 24 | $-15.3M | $22.9M | ||
| Q3 24 | $-11.7M | $6.3M | ||
| Q2 24 | $-12.3M | $5.4M | ||
| Q1 24 | $-1.9M | — |
自由现金流率CAPRSWKH
| Q4 25 | — | 308.1% | ||
| Q3 25 | — | 5.1% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 69.1% | ||
| Q4 24 | -137.3% | 185.3% | ||
| Q3 24 | -515.2% | 60.4% | ||
| Q2 24 | -310.9% | 49.7% | ||
| Q1 24 | -38.3% | — |
资本支出强度CAPRSWKH
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | 4.4% | 1.1% | ||
| Q3 24 | 0.4% | 0.3% | ||
| Q2 24 | 1.5% | 0.2% | ||
| Q1 24 | 12.4% | 0.0% |
现金转化率CAPRSWKH
| Q4 25 | — | — | ||
| Q3 25 | — | 0.10× | ||
| Q2 25 | — | 2.21× | ||
| Q1 25 | — | 1.82× | ||
| Q4 24 | — | 3.93× | ||
| Q3 24 | — | 1.82× | ||
| Q2 24 | — | 1.47× | ||
| Q1 24 | — | 9.47× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAPR
暂无分部数据
SWKH
| Finance Receivables Segment | $8.4M | 96% |
| Other | $329.0K | 4% |
